LMWH to prevent placenta‐mediated pregnancy complications: an update
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Summary: Placenta‐mediated pregnancy complications, including preeclampsia, placental abruption, intrauterine growth restriction/small for gestational age and recurrent or late pregnancy loss, affect over 5% of pregnancies and can result in significant maternal and perinatal morbidity and mortality. These complications have been suggested to at least partly arise from placental insufficiency, possibly as a result of inappropriate coagulation activation. This association has led to the hypothesis that anticoagulant therapy, such as low molecular weight heparin, might reduce their occurrence. The following review will attempt to summarize the extensive research that has been performed to date exploring this hypothesis and provide guidance on the current and future role of low molecular weight heparin in women at risk for placenta‐mediated pregnancy complications. A case will be made to question the widely adopted practice of prescribing low molecular weight heparin to women with prior placenta‐mediated pregnancy complications and suggest possible areas for future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Middeldorp, S., Veenstra, D. L., Prabulos, A.-M., & Vandvik, P. O. (2012) · Chest · doi:10.1378/chest.11-2300 · Cited by 1,525 · cited 2×
“Although the use of LMWH in patients with APLA and recurrent pregnancy loss has been widely adopted (Rai & Regan, 2006; Bates et al, 2012; Keeling et al, 2012), our review of the existing randomized control trials found inconsistencies between studies, questioning the strength of this…”
BackgroundResultRai, R., & Regan, L. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69204-0 · Cited by 1,227
Rai, R., Cohen, H., Dave, M., & Regan, L. (1997) · BMJ · doi:10.1136/bmj.314.7076.253 · Cited by 1,113
Thrombophilic disorders and fetal loss: a meta-analysis
Rey, E., Kahn, S. R., David, M., & Shrier, I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12771-7 · Cited by 872
Oyelese, Y., & Ananth, C. V. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000239439.04364.9a · Cited by 508
Previous Cesarean Delivery and Risks of Placenta Previa and Placental Abruption
Getahun, D., Oyelese, Y., Salihu, H. M., & Ananth, C. V. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000206182.63788.80 · Cited by 449
Perinatal outcome and later implications of intrauterine growth restriction
Pallotto, E. K., & Kilbride, H. W. (2006) · Clinical Obstetrics and Gynecology · doi:10.1097/00003081-200606000-00008 · Cited by 427 · cited 1×
“…increased complications compared to non-IUFR infants born at similar gestational age including sudden unexplained intrauterine death, respiratory distress, perinatal stroke as well as late sequelae such as cognitive delays and behavioural problems (Pallotto & Kilbride, 2006; Lausman et al, 2012).”
BackgroundPlacental abruption and adverse perinatal outcomes
Ananth, C. V. (1999) · JAMA · doi:10.1001/jama.282.17.1646 · Cited by 412
A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage
Brigham, S. A., Conlon, C., & Farquharson, R. G. (1999) · Human Reproduction · doi:10.1093/humrep/14.11.2868 · Cited by 365
LASKIN, C. A., SPITZER, K. A., CLARK, C. A., CROWTHER, M. R., GINSBERG, J. S., HAWKER, G. A., KINGDOM, J. C., BARRETT, J., & GENT, M. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.080763 · Cited by 352 · cited 3×
“APLA patients were analysed in a prespecified ª 2014 John Wiley & Sons Ltd 631 British Journal of Haematology, 2015, 168, 619–638 subgroup analysis in the larger, multicentre HepASA study (Laskin et al, 2009).”
BackgroundMethodResultFuture pregnancy outcome in unexplained recurrent first trimester miscarriage
Clifford, K., Rai, R., & Regan, L. (1997) · Human Reproduction · doi:10.1093/humrep/12.2.387 · Cited by 328
Noble, L. S., Kutteh, W. H., Lashey, N., Franklin, R. D., & Herrada, J. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.002 · Cited by 234 · cited 1×
“There have been several studies that compared LMWH directly to UFH in obstetrical APS patients showing no statistical difference in outcomes (Stephenson et al, 2004; Noble et al, 2005; Fouda et al, 2011), but small sample sizes limit their interpretation.”
Resultde Jong, P. G., Kaandorp, S., Di Nisio, M., Goddijn, M., & Middeldorp, S. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004734.pub4 · Cited by 204
Ziakas, P. D., Pavlou, M., & Voulgarelis, M. (2010) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181deba40 · Cited by 185 · cited 3×
“The second metaanalysis (Ziakas et al, 2010) included the five randomized controlled trials described above, using aspirin as a comparator, and reported an overall treatment effect in favour of heparin over aspirin for reduction in first trimester pregnancy loss (OR 0 39, 95% CI 0 24–0 65).”
BackgroundMethodResultInfluentialRecurrence of ischemic placental disease
Ananth, C. V., Peltier, M. R., Chavez, M. R., Kirby, R. S., Getahun, D., & Vintzileos, A. M. (2007) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000266983.77458.71 · Cited by 177
Visser, J., Ulander, V.-M., Helmerhorst, F., Lampinen, K., Morin-Papunen, L., Bloemenkamp, K., & Kaaja, R. (2011) · Thrombosis and Haemostasis · doi:10.1160/th10-05-0334 · Cited by 172
Stephenson, M. D., Ballem, P. J., Tsang, P., Purkiss, S., Ensworth, S., Houlihan, E., & Ensom, M. H. H. (2004) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)30644-2 · Cited by 140 · cited 1×
“There have been several studies that compared LMWH directly to UFH in obstetrical APS patients showing no statistical difference in outcomes (Stephenson et al, 2004; Noble et al, 2005; Fouda et al, 2011), but small sample sizes limit their interpretation.”
ResultFranklin, R. D., & Kutteh, W. H. (2002) · Human Reproduction · doi:10.1093/humrep/17.11.2981 · Cited by 92
Decreasing perinatal mortality in placental abruption
TIKKANEN, M., LUUKKAALA, T., GISSLER, M., RITVANEN, A., YLIKORKALA, O., PAAVONEN, J., NUUTILA, M., ANDERSSON, S., & METSÄRANTA, M. (2013) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12030 · Cited by 80
Cited by
Groom, K. M., & David, A. L. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.11.565 · Cited by 170
Groom, K. M., McCowan, L. M., Mackay, L. K., Lee, A. C., Said, J. M., Kane, S. C., Walker, S. P., van Mens, T. E., Hannan, N. J., Tong, S., et al. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.01.014 · Cited by 100
Care prior to and during subsequent pregnancies following stillbirth for improving outcomes
Wojcieszek, A. M., Shepherd, E., Middleton, P., Lassi, Z. S., Wilson, T., Murphy, M. M., Heazell, A. E., Ellwood, D. A., Silver, R. M., & Flenady, V. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012203.pub2 · Cited by 55
Metadata
- Authors
- Duffett, L., & Rodger, M.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2014-11-15
- Volume
- 168
- Issue
- 5
- Pages
- 619-638
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2061022771
- Cited by
- 55
- References
- 20
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.